Long-Term Effects of Bevacizumab on Vestibular Schwannoma Volume in Neurofibromatosis Type 2 Patients

Introduction  Bevacizumab offers a medical treatment that may slow the growth of vestibular schwannomas (VS) and possibly preserve hearing in patients with neurofibromatosis type 2 (NF2). This study aims to investigate the effect of long-term bevacizumab treatment on VS progression. Methods  Demogra...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Neurol Surg B Skull Base
Egile Nagusiak: Killeen, Daniel E., Klesse, Laura, Tolisano, Anthony M., Hunter, Jacob B., Kutz, Joe Walter
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Georg Thieme Verlag KG 2019
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6748845/
https://ncbi.nlm.nih.gov/pubmed/31534897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0038-1676628
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak